JAC Advance Access originally published online on August 13, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 52, 441-449
© 2003 The British Society for Antimicrobial Chemotherapy
Aetiological treatment of congenital Chagas’ disease diagnosed and monitored by the polymerase chain reaction
1 Laboratorio de Biología Molecular de la Enfermedad de Chagas, Instituto de Ingeniería Genética y Biología Molecular (INGEBI); 2 Laboratorio de Parasitología y Enfermedad de Chagas, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina
Received 14 January 2003; returned 25 March 2003; revised 2 April 2003; accepted 28 May 2003
Objectives: This prospective study focused on the evaluation of anti-parasitic therapy in congenital Chagas’ disease, diagnosed and monitored by PCR and conventional diagnosis.
Materials and methods: We studied 152 children born to seroreactive mothers, living in a non-endemic area. Fifty infants aged 0–6 months (GA) were diagnosed by microhaematocrit and PCR and 102 children aged 7 months to 17 years (GB) were diagnosed by serology and PCR. Forty treated patients were monitored for 2 or 3 years by PCR and conventional methods. A competitive-quantitative PCR was used to determine pre-therapy parasitic loads and follow their post-treatment evolution.
Results: In GA, the sensitivities of the PCR and microhaematocrit were 100% and 82.4% and their specificities 97% and 100%, respectively. In GB, the sensitivity of the PCR was 73.8% with a specificity of 100%. Pre-therapy parasitic loads ranged from 12.5 to 125 000 and 12.5 to 125 parasite genomic equivalents/mL of blood in GA and GB, respectively. PCR turned negative in all treated pre-therapy PCR positive patients before or at the end of treatment, which was followed by their seronegativation in 10/10 GA, in 3/5 children initiating therapy at 7 months to 2 years of age but in 0/16 initiating therapy at an older age. Two out of the latter patients were occasionally PCR positive during post-treatment, suggesting no parasitological response. Out of nine pre-therapy PCR negative patients, four turned seronegative after treatment, suggesting that in undetermined patients, undetectable parasitic burdens may lead to better post-treatment prognosis.
Conclusions: PCR was useful for sensitive diagnosis and therapy monitoring, allowing early detection of refractory cases.
Keywords: Trypanosoma cruzi, congenital transmission, kinetoplastid DNA, competitive PCR, parasitological cure
* Correspondence address: Vuelta de Obligado 2490, Second Floor, Buenos Aires, zip 1428, Argentina. Tel: +54-11-47832871; Fax: +54-11-47868578; E-mail: schijman{at}dna.uba.ar
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. N. Diez, S. Manattini, J. C. Zanuttini, O. Bottasso, and I. Marcipar The Value of Molecular Studies for the Diagnosis of Congenital Chagas Disease in Northeastern Argentina Am J Trop Med Hyg, April 1, 2008; 78(4): 624 - 627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Virreira, C. Truyens, C. Alonso-Vega, L. Brutus, J. Jijena, F. Torrico, Y. Carlier, and M. Svoboda Comparison of Trypanosoma cruzi Lineages and Levels of Parasitic DNA in Infected Mothers and Their Newborns Am J Trop Med Hyg, July 1, 2007; 77(1): 102 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. CAMPOS, C. BOTTO-MAHAN, S. ORTIZ, M. ACUNA, P. E. CATTAN, and A. SOLARI TRYPANOSOMA CRUZI DETECTION IN BLOOD BY XENODIAGNOSIS AND POLYMERASE CHAIN REACTION IN THE WILD RODENT OCTODON DEGUS Am J Trop Med Hyg, February 1, 2007; 76(2): 324 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. RIERA, A. GUARRO, H. E. KASSAB, J. M. JORBA, M. CASTRO, R. ANGRILL, M. GALLEGO, R. FISA, C. MARTIN, A. LOBATO, et al. CONGENITAL TRANSMISSION OF TRYPANOSOMA CRUZI IN EUROPE (SPAIN): A CASE REPORT Am J Trop Med Hyg, December 1, 2006; 75(6): 1078 - 1081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. BURGOS, S. B. BEGHER, J. M. FREITAS, M. BISIO, T. DUFFY, J. ALTCHEH, R. TEIJEIRO, H. LOPEZ ALCOBA, F. DECCARLINI, H. FREILIJ, et al. MOLECULAR DIAGNOSIS AND TYPING OF TRYPANOSOMA CRUZI POPULATIONS AND LINEAGES IN CEREBRAL CHAGAS DISEASE IN A PATIENT WITH AIDS Am J Trop Med Hyg, December 1, 2005; 73(6): 1016 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. SCHIJMAN, C. A. VIGLIANO, R. J VIOTTI, J. M. BURGOS, S. BRANDARIZ, B. E. LOCOCO, M. I. LEZE, H. A. ARMENTI, and M. J. LEVIN TRYPANOSOMA CRUZI DNA IN CARDIAC LESIONS OF ARGENTINEAN PATIENTS WITH END-STAGE CHRONIC CHAGAS HEART DISEASE Am J Trop Med Hyg, February 1, 2004; 70(2): 210 - 220. [Abstract] [Full Text] [PDF]
|
|